The product of the c-erbB-2 proto-oncogene as a target for diagnosis and therapy in breast cancer.
Dean
C J
CJ
Institute of Cancer Research and Royal Marsden Hospital, Belmont, Sutton, Surrey, UK.
Allan
S
S
Eccles
S
S
McFarlane
C
C
Styles
J
J
Valeri
M
M
Sandle
J
J
Bakir
A
A
Sacks
N
N
D000818:Animals; D000912:Antibodies, Neoplasm / Q000276:immunology; D000951:Antigens, Neoplasm / Q000032:analysis*; D014408:Biomarkers, Tumor / Q000032:analysis*; D001943:Breast Neoplasms / Q000000981:diagnostic imaging* / Q000235:genetics / Q000401:mortality / Q000473:pathology; D002277:Carcinoma / Q000000981:diagnostic imaging* / Q000235:genetics / Q000473:pathology; D002294:Carcinoma, Squamous Cell / Q000000981:diagnostic imaging / Q000235:genetics; D005060:Europe; D005260:Female; D006258:Head and Neck Neoplasms / Q000000981:diagnostic imaging / Q000473:pathology; D006801:Humans; D007553:Isotope Labeling / Q000379:methods; D008207:Lymphatic Metastasis / Q000000981:diagnostic imaging*; D051379:Mice; D008819:Mice, Nude; D009363:Neoplasm Proteins / Q000032:analysis* / Q000235:genetics / Q000276:immunology; D009367:Neoplasm Staging / Q000379:methods; D009368:Neoplasm Transplantation; D010051:Ovarian Neoplasms / Q000000981:diagnostic imaging / Q000473:pathology; D011379:Prognosis; D000090063:Proto-Oncogene Mas; D011518:Proto-Oncogene Proteins / Q000032:analysis* / Q000235:genetics / Q000276:immunology; D011519:Proto-Oncogenes; D016719:Radioimmunodetection; D018719:Erb-b2 Receptor Tyrosine Kinases; D013667:Technetium / Q000493:pharmacokinetics; D014018:Tissue Distribution; D014407:Tumor Cells, Cultured
D000912:Antibodies, Neoplasm; D000951:Antigens, Neoplasm; D014408:Biomarkers, Tumor; D009363:Neoplasm Proteins; D000090063:Proto-Oncogene Mas; D011518:Proto-Oncogene Proteins; D018719:Erb-b2 Receptor Tyrosine Kinases; D013667:Technetium; C000715470:MAS1 protein, human